이비인후과(ENT) 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2024-2030년)

ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

이비인후과(ENT) 기기 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 이비인후과 기기 시장 규모는 2030년까지 377억 2,000만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 5.54% 성장할 것으로 예상됩니다.

이 같은 성장은 노인 인구 증가, 높은 난청 유병률, 최소 침습 수술의 보급 증가 등의 요인에 기인합니다. 이 분야의 기술 발전, 질병 조기 발견을 위한 의료 투자 증가, 유리한 규제 정책 등도 시장 성장을 가속할 것으로 예상되는 요인입니다.

노년층은 나이가 들면서 면역력이 떨어질 위험이 높아져 코와 목 질환에 걸리기 쉽다. 이 문제를 해결하기 위해 노인들은 이비인후과 질환에 대한 정기적인 검진이 필요하며, 이는 이비인후과용 기기에 대한 수요 증가로 이어지고 있습니다. 영국 왕립 청각장애인협회(RNID)에 따르면, 영국에는 1,200만 명 이상이 난청을 앓고 있습니다. 이 중 40% 이상이 50대 이상, 70% 이상이 70대 이상입니다.

청력 손실은 모든 연령대의 사람들에게 영향을 미치는 흔한 만성 신체 질환입니다. 고혈압, 관절염에 이어 세 번째로 흔한 질환입니다. 특히 65세 이상 노년층에서 많이 발생하며, 3명 중 1명이 난청을 앓고 있는 것으로 알려져 있습니다. 난청은 의사소통에 악영향을 미쳐 우울증, 불안, 사회적 고립, 인지기능 저하 등을 유발합니다. 국립청각장애연구소에 따르면, 미국에서는 18세 이상 인구의 15%가 청각장애를 가지고 있을 가능성이 있습니다. 또한 여성보다 남성이 난청을 앓을 가능성이 더 높습니다.

이비인후과용 기기 시장 보고서 하이라이트

• 제품 유형별로는 보청기가 2023년 30% 이상의 가장 큰 매출 점유율을 차지할 것으로 예상되며, 보청기 기기 채택 증가와 노인 인구 증가로 인한 난청 확산으로 인해 2024년부터 2030년까지 가장 빠른 CAGR로 성장할 것으로 추정됩니다.
• 청각 임플란트 분야는 예측 기간 동안 두 번째로 빠른 CAGR로 성장할 것으로 예상됩니다. 이는 청각 임플란트 채택이 증가하고 있으며, 비침습적 시술로 인공와우에 대한 인식이 높아졌기 때문입니다.
• 북미는 청력 관리 기기에 대한 수요 증가, 대규모 병원 체인의 존재, 고도의 시설을 갖춘 외래 환자 시설, 많은 대상 인구 등 여러 요인으로 인해 2023년 시장을 장악했습니다.
• 2023년 2월, Innovia Medical은 영국에서 열린 BACO International 2023에서 Summit of Medical ENT 제품군을 발표했습니다. 이 제품군에는 환기 튜브 및 그로멧, 덴버 부목, 흡수성 비강 및 부비동 팩, Rhino Rocket 등 다양한 프리미엄 필수품이 포함되어 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 이비인후과(ENT) 기기 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 이비인후과(ENT) 기기 시장 분석 툴
  • Porter의 Five Forces 분석
  • PESTEL 분석

제4장 이비인후과(ENT) 기기 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 이비인후과(ENT) 기기 시장 : 제품별 변동 분석, 100만 달러, 2023년 및 2030년

제5장 이비인후과(ENT) 기기 시장 : 지역별 추정·동향 분석

• 세계의 지역 시장 스냅숏
• 이비인후과(ENT) 기기 시장 점유율, 지역별, 2023년 및 2030년, 100만 달러
• 북미
  • 북미의 이비인후과(ENT) 기기 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 유럽의 이비인후과(ENT) 기기 시장 추산·예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 스페인
  • 이탈리아
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 이비인후과(ENT) 기기 시장 추산·예측, 2018-2030년
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카의 이비인후과(ENT) 기기 시장 추산·예측, 2018-2030년
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 이비인후과(ENT) 기기 시장 추산·예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제6장 경쟁 구도

• 기업 분류
• 기업 시장 현황 분석
• 전략 매핑
• 기업 개요
  • Ambu A/S
  • Cochlear Ltd.
  • Demant A/S
  • GN Store Nord A/S
  • Karl Storz
  • Olympus Corporation
  • PENTAX Medical
  • Richard Wolf GmbH
  • Rion Co., Ltd.
  • Smith &Nephew plc
  • Sonova
  • Starkey Laboratories, Inc.
  • Stryker
  • Nico Corporation
  • Nemera.

LSH

영문 목차

영문목차

ENT Devices Market Growth & Trends:

The global ENT devices market size is anticipated to reach USD 37.72 billion by 2030, growing at a CAGR of 5.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market's growth.

The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s & above, and more than 70% of people were in the 70s & above.

Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.

ENT Devices Market Report Highlights:

• Based on product type, hearing aids held the largest revenue share of over 30% in 2023 and is estimated to grow at the fastest CAGR from 2024 to 2030, owing to the increasing adoption of hearing aids devices and the prevalence of hearing loss due to the growing geriatric population
• The hearing implants segment is expected to grow at the second fastest CAGR over the forecast period. This can be attributed to the increasing adoption of hearing implants, rising awareness about cochlear implants as non-invasive procedures
• North America dominated the market in 2023, due to several factors such as increased demand for hearing care devices, the presence of large hospital chains, highly equipped ambulatory facilities, and a significant target population
• In February 2023, Innovia Medical launched the Summit of Medical ENT product range at BACO International 2023 held in the UK. The product range featured various premium essentials, including Ventilation Tubes and Grommets, Denver Splint, AbsorbENT Nasal and Sinus Packs, and Rhino Rocket

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. ENT Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. High prevalence of hearing loss
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Increasing penetration of minimally invasive ENT procedures
    • 3.2.1.4. Technological advancements in ENT devices
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of hearing devices
• 3.3. ENT Devices Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. ENT Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. ENT Devices Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.2.1. Diagnostic ENT Devices
    • 4.2.1.1. Diagnostic ENT Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.2. Rigid endoscopes
    • 4.2.1.2.1. Rigid endoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.2.2. Sinuscopes
    • 4.2.1.2.2.1. Sinuscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.2.3. Otoscopes
    • 4.2.1.2.3.1. Otoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.2.4. Laryngoscopes
    • 4.2.1.2.4.1. Laryngoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.3. Flexible endoscopes
    • 4.2.1.3.1. Flexible endoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.3.2. Bronchoscopes
    • 4.2.1.3.2.1. Bronchoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.3.3. Laryngoscopes
    • 4.2.1.3.3.1. Laryngoscopes market, 2018 - 2030 (USD Million)
    • 4.2.1.3.4. Nasopharyngoscopes
    • 4.2.1.3.4.1. Nasopharyngoscopes market, 2018- 2030 (USD Million)
    • 4.2.1.4. Robot assisted endoscope
    • 4.2.1.4.1. Robot assisted endoscope market, 2018 - 2030 (USD Million)
    • 4.2.1.5. Hearing screening device
    • 4.2.1.5.1. Hearing screening device market, 2018 - 2030 (USD Million)
  • 4.2.2. Surgical ENT Devices
    • 4.2.2.1. Surgical ENT devices market, 2018 - 2030 (USD Million)
    • 4.2.2.2. Radiofrequency handpieces
    • 4.2.2.2.1. Radiofrequency handpieces market, 2018 - 2030 (USD Million)
    • 4.2.2.3. Otological drill burrs
    • 4.2.2.3.1. Otological drill burrs market, 2018 - 2030 (USD Million)
    • 4.2.2.4. ENT hand instruments
    • 4.2.2.4.1. ENT hand instruments market, 2018 - 2030 (USD Million)
    • 4.2.2.5. Sinus dilation devices
    • 4.2.2.5.1. Sinus dilation devices market, 2018 - 2030 (USD Million)
    • 4.2.2.6. Nasal packing devices
    • 4.2.2.6.1. Nasal packing devices market, 2018 - 2030 (USD Million)
  • 4.2.3. Hearing Aids
    • 4.2.3.1. Hearing aids market, 2018 - 2030 (USD Million)
  • 4.2.4. Hearing Implants
    • 4.2.4.1. Hearing implants market, 2018 - 2030 (USD Million)
  • 4.2.5. Nasal Splints
    • 4.2.5.1. Nasal splints market, 2018 - 2030 (USD Million)

Chapter 5. ENT Devices Market: Regional Estimates & Trend Analysis

• 5.1. Global Regional Market Snapshot
• 5.2. ENT Devices Market Share, By Region, 2023 & 2030, USD Million
• 5.3. North America
  • 5.3.1. North America ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework/ reimbursement structure
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. U.S. ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Regulatory framework/ reimbursement structure
    • 5.3.3.3. Competitive scenario
    • 5.3.3.4. Canada ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. UK
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. UK ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Germany
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. Germany ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework/ reimbursement structure
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. France ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5. Spain
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework/ reimbursement structure
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Spain ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.6. Italy
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Regulatory framework/ reimbursement structure
    • 5.4.6.3. Competitive scenario
    • 5.4.6.4. Italy ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Regulatory framework/ reimbursement structure
    • 5.4.7.3. Competitive scenario
    • 5.4.7.4. Denmark ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Regulatory framework/ reimbursement structure
    • 5.4.8.3. Competitive scenario
    • 5.4.8.4. Sweden ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamics
    • 5.4.9.2. Regulatory framework/ reimbursement structure
    • 5.4.9.3. Competitive scenario
    • 5.4.9.4. Norway ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. China
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. China ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Japan
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework/ reimbursement structure
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. Japan ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework/ reimbursement structure
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. India ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework/ reimbursement structure
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. South Korea ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Australia
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework/ reimbursement structure
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Australia ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Thailand
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Regulatory framework/ reimbursement structure
    • 5.5.7.3. Competitive scenario
    • 5.5.7.4. Thailand ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Brazil ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. Mexico
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework/ reimbursement structure
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. Mexico ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. Argentina
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework/ reimbursement structure
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. Argentina ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Middle East and Africa
  • 5.7.1. Middle East and Africa ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. South Africa ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework/ reimbursement structure
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. Saudi Arabia ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework/ reimbursement structure
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. UAE ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Regulatory framework/ reimbursement structure
    • 5.7.5.3. Competitive scenario
    • 5.7.5.4. Kuwait ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis
• 6.3. Strategy Mapping
• 6.4. Company Profiles
  • 6.4.1. Ambu A/S
    • 6.4.1.1. Participant's Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiative
  • 6.4.2. Cochlear Ltd.
    • 6.4.2.1. Participant's Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiative
  • 6.4.3. Demant A/S
    • 6.4.3.1. Participant's Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiative
  • 6.4.4. GN Store Nord A/S
    • 6.4.4.1. Participant's Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiative
  • 6.4.5. Karl Storz
    • 6.4.5.1. Participant's Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiative
  • 6.4.6. Olympus Corporation
    • 6.4.6.1. Participant's Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiative
  • 6.4.7. PENTAX Medical
    • 6.4.7.1. Participant's Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiative
  • 6.4.8. Richard Wolf GmbH
    • 6.4.8.1. Participant's Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiative
  • 6.4.9. Rion Co., Ltd.
    • 6.4.9.1. Participant's Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiative
  • 6.4.10. Smith & Nephew plc
    • 6.4.10.1. Participant's Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic Initiative
  • 6.4.11. Sonova
    • 6.4.11.1. Participant's Overview
    • 6.4.11.2. Financial Performance
    • 6.4.11.3. Product Benchmarking
    • 6.4.11.4. Strategic Initiative
  • 6.4.12. Starkey Laboratories, Inc.
    • 6.4.12.1. Participant's Overview
    • 6.4.12.2. Financial Performance
    • 6.4.12.3. Product Benchmarking
    • 6.4.12.4. Strategic Initiative
  • 6.4.13. Stryker
    • 6.4.13.1. Participant's Overview
    • 6.4.13.2. Financial Performance
    • 6.4.13.3. Product Benchmarking
    • 6.4.13.4. Strategic Initiative
  • 6.4.14. Nico Corporation
    • 6.4.14.1. Participant's Overview
    • 6.4.14.2. Financial Performance
    • 6.4.14.3. Product Benchmarking
    • 6.4.14.4. Strategic Initiative
  • 6.4.15. Nemera.
    • 6.4.15.1. Participant's Overview
    • 6.4.15.2. Financial Performance
    • 6.4.15.3. Product Benchmarking
    • 6.4.15.4. Strategic Initiative

관련자료